docetaxel,darolutamide
bayer
['nubeqa', 'darolutamide', 'prostate', 'arasens', 'bayer']
#bayer reported new #nubeqa (#darolutamide) subgroup analyses from the phase iii #arasens trial in metastatic hormone-sensitive #prostatecancer (mhspc) patients presented at #ascogu23 
Follow top-line development in the oncology commercial domain through our award winning intelligence service, 1stOncology.